Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ling Ni

Showing results (1-10 of 215) with videos related to

Pageof 22
Sort By:
Frontiers in Immunology|May 27, 2022
Advances in Human Dendritic Cell-Based Immunotherapy Against Gastrointestinal CancerLing Ni
Clinical and Translational Medicine|August 22, 2024
Potential mechanisms of cancer stem-like progenitor T-cell bio-behavioursLing Ni
Vaccines|October 28, 2023
Advances in mRNA-Based Cancer VaccinesLing Ni
Cancer Medicine|July 25, 2018
Interferon gamma in cancer immunotherapyLing Ni, Jian Lu
Molecular Cancer Therapeutics|July 7, 2017
New B7 Family Checkpoints in Human CancersLing Ni, Chen Dong
Immunological Reviews|March 5, 2017
New checkpoints in cancer immunotherapyLing Ni, Chen Dong
Frontiers in Immunology|July 7, 2018
Roles of Myeloid and Lymphoid Cells in the Pathogenesis of Chronic Obstructive Pulmonary DiseaseLing Ni, Chen Dong
Journal of Biomedical Nanotechnology|April 20, 2021
Anti-Human Epidermal Growth Factor Receptor 2 Single-Chain Fv Fragment-Decorated DM1 Nanoparticles for Specific Targeting of Human Epidermal Growth Factor Receptor 2-Positive Breast Tumor CellsLing Ni, You-Xin Li
Antibiotics (Basel, Switzerland)|October 23, 2021
First Experimental Evidence for the Presence of Potentially Virulent <i>Klebsiella oxytoca</i> in 14 Species of Commonly Consumed Aquatic Animals, and Phenotyping and Genotyping of <i>K</i><i>. oxytoca</i> IsolatesLing Ni, Yingwei Xu, Lanming Chen
Current Opinion in Immunology|February 13, 2017
Immune checkpoint receptors in cancer: redundant by design?Jing Li, Ling Ni, Chen Dong
Pageof 22

Showing results (1-10 of 215) with videos related to

Sort By:
Pageof 22
Frontiers in Immunology|May 27, 2022
Advances in Human Dendritic Cell-Based Immunotherapy Against Gastrointestinal CancerLing Ni
Clinical and Translational Medicine|August 22, 2024
Potential mechanisms of cancer stem-like progenitor T-cell bio-behavioursLing Ni
Vaccines|October 28, 2023
Advances in mRNA-Based Cancer VaccinesLing Ni
Cancer Medicine|July 25, 2018
Interferon gamma in cancer immunotherapyLing Ni, Jian Lu
Molecular Cancer Therapeutics|July 7, 2017
New B7 Family Checkpoints in Human CancersLing Ni, Chen Dong
Immunological Reviews|March 5, 2017
New checkpoints in cancer immunotherapyLing Ni, Chen Dong
Frontiers in Immunology|July 7, 2018
Roles of Myeloid and Lymphoid Cells in the Pathogenesis of Chronic Obstructive Pulmonary DiseaseLing Ni, Chen Dong
Journal of Biomedical Nanotechnology|April 20, 2021
Anti-Human Epidermal Growth Factor Receptor 2 Single-Chain Fv Fragment-Decorated DM1 Nanoparticles for Specific Targeting of Human Epidermal Growth Factor Receptor 2-Positive Breast Tumor CellsLing Ni, You-Xin Li
Antibiotics (Basel, Switzerland)|October 23, 2021
First Experimental Evidence for the Presence of Potentially Virulent <i>Klebsiella oxytoca</i> in 14 Species of Commonly Consumed Aquatic Animals, and Phenotyping and Genotyping of <i>K</i><i>. oxytoca</i> IsolatesLing Ni, Yingwei Xu, Lanming Chen
Current Opinion in Immunology|February 13, 2017
Immune checkpoint receptors in cancer: redundant by design?Jing Li, Ling Ni, Chen Dong
Pageof 22